Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational studyAndrew Ip, Stuart L. Goldberg, Urszula Bednarz et al.|PLoS ONE|2020Cited by 144
Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients – An Observational StudyAndrew Ip, Stuart L. Goldberg, Donald A. Berry et al.|medRxiv|2020Cited by 69
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high‐risk multiple myelomaNoa Biran, David S. Siegel|American Journal of Hematology|2021Cited by 9